Skip to main content
Premium Trial:

Request an Annual Quote

UBS Warburg Starts Coverage of Luminex With a Buy

NEW YORK, Dec. 10 - UBS Warburg on Monday began research coverage of Luminex with a "buy" rating and a $21 price target, according to the financial firm.  


Citing Luminex's strengths and focus on the diagnostic market, UBS said it expects the company to post revenues of $42.6 million and a loss of 35 cents per share for 2002.


Shares of the Austin, Tex.-based bead-array developer climbed 1.39 percent, or 23 cents, to $16.79 in Nasdaq trading early on Monday. The company's 52-week trading range is $11.95 to $36.19.


Luminex is known chiefly for its LabMap technology, which beside genomics and proteomics research is used in pharmaceutical drug discovery, clinical diagnostics, and biomedical research.


In September, the American Society of Histocompatibility and Immunogenetics cleared Orchid Biosciences to perform human leukocyte antigen testing using the LabMap platform. Orchid becomes the first firm to be certified to perform the testing with the LabMap technology.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.